Antagonist Effect of a Receptor-Mimicking Peptide Encoded by Human Angiotensin II Complementary RNA

Hypertension - United States
doi 10.1161/01.hyp.19.4.345
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Non-Peptide Angiotensin II Receptor Antagonists.

Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry
Organic Chemistry
1995English

Localization of a Novel Non-Peptide Angiotensin II Type 1 Receptor Antagonist, E4177, in Rat Adrenal Glomerulosa.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
1996English

Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure

Case Reports in Pediatrics
2018English

Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Effect of the Angiotensin II Receptor Antagonist Losartan on Uric Acid and Oxypurine Metabolism in Healthy Subjects.

Internal Medicine
Internal MedicineMedicine
2002English

Reduction of Bleomycin Induced Lung Fibrosis by Candesartan Cilexetil, an Angiotensin II Type 1 Receptor Antagonist

Thorax
PulmonaryRespiratory Medicine
2004English

In Vitro Pharmacological Properties of KRH-594, a Novel Angiotensin II Type 1 Receptor Antagonist.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
1997English

Contribution of Angiotensin Converting Enzyme Gene Polymorphism to the Action of Angiotensin II Receptor Antagonist (CS-866).

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2002English

The Effect of Angiotensin II Receptor Blockers on Hyperuricemia

Therapeutic Advances in Chronic Disease
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy